Dannielle Appelhans

Insider Reports History

Location
C/O Rubius Therapeutics, Inc., 399 Binney Street, Suite 300, Cambridge, MA
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dannielle Appelhans:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Generation Bio Co. Director Stock Option (right to buy) 30K $275K $4.59 Jun 4, 2025 Direct
Rubius Therapeutics, Inc. CEO and President Restricted Stock Units 22.5K Jan 31, 2023 Direct
Rubius Therapeutics, Inc. CEO and President Common Stock 0 Feb 24, 2023 Direct

Insider Reports Filed by Dannielle Appelhans

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GBIO Generation Bio Co. Jun 4, 2025 1 $0 4 Jun 6, 2025 Director
GBIO Generation Bio Co. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
GBIO Generation Bio Co. Dec 8, 2023 2 $14.3K 4 Dec 11, 2023 Director
GBIO Generation Bio Co. Dec 4, 2023 1 $18K 4 Dec 6, 2023 Director
GBIO Generation Bio Co. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
RUBY Rubius Therapeutics, Inc. Feb 24, 2023 1 -$1.32K 4 Feb 27, 2023 CEO and President
RUBY Rubius Therapeutics, Inc. Jan 31, 2023 3 -$970 4 Feb 1, 2023 CEO and President
RUBY Rubius Therapeutics, Inc. Aug 9, 2022 3 -$4.59K 4 Aug 12, 2022 Chief Operating Officer
GBIO Generation Bio Co. Jul 15, 2022 1 $0 4 Jul 19, 2022 Director
GBIO Generation Bio Co. Jul 15, 2022 0 $0 3 Jul 19, 2022 Director
RUBY Rubius Therapeutics, Inc. Jan 31, 2022 2 $0 4 Feb 1, 2022 Chief Operating Officer
RUBY Rubius Therapeutics, Inc. Aug 31, 2021 2 $0 4 Sep 1, 2021 Chief Operating Officer
RUBY Rubius Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 16, 2021 Chief Operating Officer